Skip to main content
Back to sections

MoonLake Immunotherapeutics

For the period ended Jun 4, 2026. Filed Apr 21, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 4, 2026 · Filed Apr 21, 2026

MLTX$11.53+6.8%Stored close · as of Nov 6, 2026
Opening this filing…

The words and numbers in each frame are the filing's, as the company filed them with the SEC. Where a filing is data, we made the labels and headings from its field names, and added commas to its long numbers. This is not investment advice.